Valuation: Certara, Inc.

Market Cap 1.17B 1.03B 954M 876M 1.65B 113B 1.67B 11.33B 4.43B 55.31B 4.39B 4.29B 191B P/E 2026 *
-75.1x
P/E 2027 * -751x
Enterprise Value 1.24B 1.09B 1.02B 932M 1.75B 120B 1.78B 12.06B 4.71B 58.85B 4.67B 4.57B 203B EV / Sales 2026 *
3.12x
EV / Sales 2027 * 2.84x
Free-Float
69.21%
Yield 2026 *
-
Yield 2027 * -
1 day+5.63%
1 week+8.37%
Current month+14.66%
1 month+36.79%
3 months+18.83%
6 months-24.90%
Current year-14.76%
1 week 6.69
Extreme 6.69
7.6
1 month 5.81
Extreme 5.81
7.6
Current year 4.45
Extreme 4.45
10.2
1 year 4.45
Extreme 4.45
13.88
3 years 4.45
Extreme 4.45
19.87
5 years 4.45
Extreme 4.45
45.48
10 years 4.45
Extreme 4.45
45.48
Manager TitleAgeSince
Chief Executive Officer 53 01/01/2026
Director of Finance/CFO 53 15/07/2026
President 62 01/08/2023
Director TitleAgeSince
Director/Board Member 59 01/08/2017
Director/Board Member 67 11/07/2022
Chairman 72 01/12/2021
Date Insider Type Main position Quantity % Market Cap.
7/15/26 A Other

Chief Financial Officer

191,850 0.1233%
6/1/26 A Fiscal year

General Counsel

57,763 0.0371%
6/1/26 A Fiscal year

Head of Human Resources

16,535 0.0106%
Change 5-day change 1-year change 3-year change Capi.($)
+5.63%+8.37%-32.28%-60.39% 1.17B
+0.03%-3.08%-25.70%+8.75% 2,835B
-0.36%-7.15%-22.59%+642.72% 295B
-1.92%+2.89%+171.09%+992.96% 114B
-1.28%-1.17%-1.79%+36.91% 89.98B
+1.01%-4.57%+64.75%+114.10% 87.87B
-0.01%-2.81%-37.92%-18.18% 71.51B
+0.50%-3.89%-36.59%+63.93% 61.25B
+0.61%-2.13%+3.07%+53.38% 43.01B
0.00%-7.99%-59.98%+19.89% 34.04B
Average +0.42%-2.66%+2.21%+185.41% 363.26B
Weighted average by Cap. -0.06%-4.72%-16.92%+95.23%

Financials

2026 *2027 *
Net sales 399M 350M 326M 299M 561M 38.39B 570M 3.87B 1.51B 18.87B 1.5B 1.46B 65.25B 405M 356M 331M 304M 571M 39.05B 580M 3.93B 1.54B 19.2B 1.52B 1.49B 66.37B
Net income -16.86M -14.81M -13.77M -12.63M -23.74M -1.62B -24.11M -164M -63.88M -798M -63.28M -61.92M -2.76B -2.39M -2.1M -1.95M -1.79M -3.36M -230M -3.41M -23.16M -9.05M -113M -8.96M -8.77M -391M
Net Debt 74.77M 65.67M 61.07M 56.04M 105M 7.2B 107M 725M 283M 3.54B 281M 275M 12.24B -17.2M -15.1M -14.05M -12.89M -24.22M -1.66B -24.59M -167M -65.17M -814M -64.56M -63.17M -2.82B
Logo Certara, Inc.
Certara, Inc. is a provider of biosimulation technology and solutions for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical industry. It accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. It delivers software products and technology-driven services to customers to carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services, such as regulatory submissions software, natural language processing and Bayesian analytics. It offers both mechanistic and empirical biosimulation solutions, providing clients with a comprehensive offering based on their therapy goals, mechanism of action, and available data sources. Its clients include 2,600 biopharmaceutical companies, academic institutions and biotech companies across 70 countries.
Employees
1,546
Date Price Change Volume
24/07/26 $7.510 +5.63% 5,624,248
23/07/26 $7.110 +3.19% 3,347,858
22/07/26 $6.890 +0.58% 2,072,675
21/07/26 $6.850 -1.30% 2,638,926
20/07/26 $6.940 +0.14% 1,942,183
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
7.510USD
Average target price
7.530USD
Spread / Average Target
+0.27%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CERT Stock